2017. ISPOR European Congress – Symptom deterioration in patients with metastatic renal cell carcinoma treated with cabozantinib or everolimus

Marteau F, Beaumont J, Gabriel S, Hankins M, Mandeshkar M, Williams P, et al. Symptom deterioration in patients with metastatic renal cell carcinoma treated with cabozantinib or everolimus. Value Health. 2017 Oct-Nov;20(9):A455. Presented at: ISPOR 20th European Meeting: November 4-8, 2017; Glasgow, UK.